Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Transgene included last patient in Phase 2 trial testing TG4010 in combination with Opdivo
May 28, 2019 Off

Transgene included last patient in Phase 2 trial testing TG4010 in combination with Opdivo

By BusinessWire

Transgene confirms that the study’s primary
endpoint (objective response rate – ORR) on a minimum of 35 evaluable
patients will be reported in Q4 2019.

Pfizer’s Phase 3 Trial of LYRICA in primary generalized tonic-clonic seizures misses target
May 28, 2019 Off

Pfizer’s Phase 3 Trial of LYRICA in primary generalized tonic-clonic seizures misses target

By BusinessWire

The LYRICA Pediatric Epilepsy Program is composed of six studies in
patients with epilepsy evaluating LYRICA as adjunctive therapy, five of
which have been completed.

Aggrastat boosts Medicure’s revenues, shrinks 1Q net loss over last year’s
May 28, 2019 Off

Aggrastat boosts Medicure’s revenues, shrinks 1Q net loss over last year’s

By Dino Mustafić

Medicure Inc reported net loss for the quarter ended March 31, 2019 at $2.8 million compared to net income of $1.4 million for the quarter ended March 31, 2018.

FDA Approves Jakafi for the Treatment of Patients with Acute Graft-Versus-Host Disease
May 28, 2019 Off

FDA Approves Jakafi for the Treatment of Patients with Acute Graft-Versus-Host Disease

By BusinessWire

Jakafi is the first and only FDA-approved treatment for patients with
steroid-refractory acute graft-versus-host disease (GVHD)

May 28, 2019 Off

Wharton Research Data Services Adds Healthbase to Growing List of Healthcare Data

By BusinessWire

PHILADELPHIA–(BUSINESS WIRE)–Wharton Research Data Services (WRDS), the leading data research platform and business intelligence tool for corporate, academic and government…

May 27, 2019 Off

Global Orphan Drugs (Biologics, and Non-Biologics) Market Analysis, Trends, and Forecasts Report 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Orphan Drugs – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The report provides…

May 27, 2019 Off

Biosimulation Market to Grow by USD 1.42 Billion During 2019-2023 | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–Technavio’s latest market research report on the global biosimulation market predicts the market to witness a CAGR…

May 27, 2019 Off

Global Gene Therapy for Inherited Genetic Disorders Market 2019-2023 | Increasing Strategic Alliances to Boost Growth | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global gene therapy for inherited genetic disorders market is expected to post a CAGR of about…

May 27, 2019 Off

Global Hearing Implant Market by Type (Cochlear Implant, Bone Anchored Hearing Aid, Acoustic Brainstem Implant, Middle Ear Implant), End-user (Adults, Pediatrics), Region & Country: Forecast to 2023 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hearing Implant Market – Analysis By Type (Cochlear Implant, Bone Anchored Hearing Aid, Acoustic Brainstem Implant, Middle…

May 27, 2019 Off

Global Biopharmaceutical CMO Market Outlook to 2023 Featuring Lonza, Boehringer Ingelheium, Samsung Biologics, and Wuxi Biologics – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Biopharmaceutical CMO Market – Analysis By Region, By Country: Opportunities and Forecast (2018-2023) — By Region (North…

Posts pagination

Previous 1 … 3,164 3,165 3,166 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine